INBS 10-K: Going Concern Warning, $12.4M Loss, but Revenue Up 38%
INBS has more than doubled off its 52-week low of $1.52.
Summary
Intelligent Bio Solutions filed its annual report with a going concern warning, a wider net loss of $12.4 million, but strong revenue growth of 38% and remediation of internal control weaknesses.
Key Events · Earnings and Guidance · INBS
-
Going Concern Warning
Cash of $3.99 million as of June 30, 2026, is insufficient to fund operations for the next 12 months, raising substantial doubt about the company's ability to continue as a going concern.
-
Net Loss Widens
Net loss attributable to INBS increased to $12.43 million from $10.57 million, driven by higher selling, general, and administrative expenses and development costs.
-
Revenue Growth
Revenue grew 38.1% to $4.22 million, with cartridge sales up 41.1%, and gross margin improved to 48.6% from 40.9%.
-
Internal Controls Remediated
Management concluded that previously reported material weaknesses in internal control over financial reporting were remediated as of June 30, 2026.
Analysis · INBS · Industrial Applications And Services
The annual report confirms the company's cash of $3.99 million is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. Net loss widened to $12.43 million from $10.57 million, driven by higher selling and regulatory expenses. Revenue grew 38.1% to $4.22 million, and gross margin improved to 48.6%. Management remediated previously reported material weaknesses in internal controls. The company has 6.1 million warrants outstanding and continues to raise capital through an ATM facility, with $4.29 million raised through August 18, 2026.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.6% of the 978 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INBS was trading at $3.22 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $1.52 to $24.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.